GSK Managing Director Paul Lirette said the Boronia upgrade was part of the company's $US2 billion ($2.67 billion) global expansion "to boost our global supply capacity"
"To boost our global supply capacity"...of what???
Mate, if they only spent 21 mil on the boronia plant, they aren't going to spend US 2 Bil on Relenza alone...
he must be referring to relenza + vaccines and possibly other supply capacity
boronia opening today, page-3
-
- There are more pages in this discussion • 32 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)